Hepatic Adenomas in Adolescents and Young Women with Endometriosis Treated with Norethindrone Acetate

NET-A in a dose greater than 10 mg/d might be associated with increased risk for hepatic adenomas, likely due to peripheral conversion to ethinyl estradiol. Use of NET-A might not be advisable in patients with known hepatic adenomas.